Future4Care announces the second cohort of startups for its Go-To-Market Program

We are proud to announce the startups selected for the second edition of Future4care’s Go-To-Market Program, our one-year, equity-free initiative designed to support digital health startups accelerating their entry into the French and German healthcare markets. 

Following a global call and a rigorous selection process, this new cohort brings together innovative companies addressing some of Europe’s most pressing healthcare challenges across PharmaTech, Prevention, Hospital Innovation, and Healthy Aging. 

A program designed for real market entry

Entering the European healthcare market, particularly France and Germany, requires more than a strong product. Regulatory complexity, reimbursement pathways, fragmented stakeholder landscapes, and country-specific dynamics demand deep local expertise and the right connections. 

The Go-To-Market Program was created to address precisely these challenges. Over the course of one year, selected startups benefit from: 

• Strategic market entry deep dives into France and Germany 

• Personalized, one-on-one mentorship with healthcare, regulatory, and industry experts 

• Educational workshops covering regulation, reimbursement, pharma, insurance, and hospital systems 

• Access to a curated ecosystem of mentors and experts from corporates, providers, investors, and decision-makers 

• High-impact visibility, including participation in Future4care Demo Day 2026 in Paris, with a dedicated exhibition space 

The program follows a hybrid engagement model and is open to startups from anywhere in the world that share a strong ambition to explore and de-risk their European expansion. 

The selected startups – Go-To-Market Program Cohort 2025–2026

We are delighted to welcome the following startups into the second cohort: 

Bonescreen (Germany) 
Bonescreen develops AI-powered solutions that extract additional clinical insights from routine medical imaging. Its CE-certified product, SpineQ, analyzes CT scans to support osteoporosis diagnosis and fracture risk assessment at scale. 

BrainTrip (Malta) 
BrainTrip develops AI-based solutions to quantify brain health through short, objective assessments. Its NeuroAI platform enables brain screening applications to assess cognitive health, support early dementia detection, and estimate brain biological age. 

Docs4D (Germany) 
Docs4D enables semi-automatic and seamless health monitoring through digital treatment pathways, supporting structured and continuous patient follow-up. 

Doctor One (France) 
Doctor One is a chronic care platform enabling continuous, asynchronous communication between healthcare professionals and patients. By extending care beyond in-person visits, it supports patient engagement, adherence, and long-term care relationships. 

Imaginostics (United States) 
Imaginostics develops next-generation medical imaging solutions focused on vascular health. Its platform combines advanced MRI imaging, analytics, and digital twins to enable early detection and support a shift from reactive to preventive care, including applications in drug discovery. 

Magic Genomix (France) 
Magic Genomix is a precision oncology company leveraging genomic instability biomarkers to support patient stratification. Its approach improves therapy matching, clinical trial efficiency, and drug development in aggressive cancers. 

Myvitale (Spain) 
Myvitale develops AI-powered personalized coaching programs for physical activity, nutrition, and lifestyle, supporting the prevention and management of metabolic and chronic diseases. Its clinically oriented platform delivers individualized recommendations and is expanding across Europe to bridge medical and lifestyle interventions. 

O2 (United States) 
O2 is a brain-tech company developing digital therapeutics for pediatric hospitals, combining neuroscience with art, sound, and immersive technology. Its solutions support children’s emotional regulation and wellbeing through clinically informed, play-based experiences. 

Patientory, Inc. (United States) 
Patientory develops blockchain- and AI-enabled solutions for secure health data management and sharing. Its platforms give individuals greater control over their medical data while supporting care coordination, research participation, and data-driven healthcare collaboration. 

RareSum (Turkey) 
RareSum develops AI-driven solutions using medical language models and NLP to transform complex EHR data into clinical and operational insights. Its platform supports coding optimization, automated documentation, and clinical decision support for rare and hard-to-diagnose diseases, with GDPR-compliant deployments. 

SISU Health (Australia/United Kingdom) 
SISU Health delivers digital prevention and early-intervention solutions through self-service health stations and connected digital journeys. Its platform empowers individuals to understand and improve their health while generating real-time population health insights for health systems, governments, and employers. 

Sleep2 (Austria) 
Sleep2 is a digital health company and spin-off of the University of Salzburg, developing CE-marked digital medical solutions for sleep health. Its platform objectively measures sleep using HRV and improves sleep through guideline-based CBT-I, with a strong focus on transparency, data protection, and measurable outcomes. 

TALOS Corp. (South Korea) 
TALOS Corp. develops AI-driven solutions for the early detection of cardiovascular and cerebrovascular disease risks. Its flagship product analyzes routine health checkup data to support the identification of cerebral aneurysm risk, enabling earlier and more preventive care. 

A strong European digital health ecosystem

Founded in 2021 by Capgemini, Generali, Orange, and Sanofi, Future4care has grown into a leading European launchpad for digital health innovation. The ecosystem brought together more than 150 partners and startups, fostering cross-sector collaboration across healthcare, technology, insurance, and life sciences. 

By combining corporate expertise with startup agility, Future4care aims to enable sustainable innovation across Europe’s fragmented healthcare systems, turning promising solutions into market-ready, scalable impact. 

Looking ahead

The program officially kicked off on November 3rd, 2025, and will culminate a year later. Over the coming months, the cohort will work closely with mentors, partners, and peers to build robust market entry strategies and lay the foundation for long-term European growth. 

We look forward to supporting this group of founders on their journey and to sharing insights, progress, and outcomes along the way!